Orion Oyj (ORINF)
PNK – Real vaqt narxi. Valyuta: USD
82.75
0.00 (0.00%)
Yopilishda: Sep 9, 2026, 4:00 PM EDT
Find any stock by ticker or company name

PNK – Real vaqt narxi. Valyuta: USD
82.75
0.00 (0.00%)
Yopilishda: Sep 9, 2026, 4:00 PM EDT
Orion Oyj Finlandiyada, Skandinaviyada, Yevropaning qolgan qismida, Shimoliy Amerikada va xalqaro miqyosda inson va hayvonlar uchun dori-darmonlar hamda faol farmatsevtik moddalarni (API) ishlab chiqadi, ishlab chiqaradi va sotadi. U prostata saratonini davolash uchun Nubeqa; Parkinson kasalligini davolash uchun Entacapone, Stalevo, Comtess va Comtan; yallig'lanishli og'riq uchun Burana; menopauza alomatlari uchun Divina seriyasi; o'tkir dekompensatsiyalangan yurak etishmovchiligi uchun Simdax; ko'krak bezi saratoni uchun Fareston; antipsixotik vositalar uchun Quetiapine mahsulotlari; revmatoid artrit va saraton uchun Trexan; astma va KOAH uchun Easyhaler mahsulot portfeli; va inson uchun Dexdor, Precedex va Dexmedetomidine mahsulotlarini o'z ichiga olgan farmatsevtik mahsulotlarni taklif etadi. Kompaniya, shuningdek, astma va surunkali obstruktiv o'pka kasalligini davolash uchun Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler va Buventol Easyhaler dorilarini taqdim etadi. Bundan tashqari, u Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo va Tessie kabi hayvonlar uchun dorilarni; umumiy birikmalar va patentlangan mahsulotlar uchun APIlarni, shuningdek, shartnoma asosida ishlab chiqarish xizmatlarini taklif etadi; va boshqa kompaniyalar tomonidan ishlab chiqarilgan dorilar va mahsulotlarni sotadi. Bundan tashqari, kompaniya retseptsiz dori-darmonlar, kosmetika, parhez qo'shimchalari, vitaminlar va terini parvarish qilish vositalarini o'z ichiga olgan o'z-o'zini parvarish qilish mahsulotlarini taqdim etadi. Kompaniya o'z mahsulotlarini onlayn tarzda ham taklif etadi. Kompaniya yurak etishmovchiligi bilan bog'liq o'pka gipertenziyasini (PH-HFpEF) davolash uchun og'iz orqali levosimedan (TNX-103) ishlab chiqish bo'yicha Tenax Therapeutics, Inc. bilan va darolutamid Nubeqa'ni ishlab chiqish va tijoratlashtirish bo'yicha Bayer bilan litsenziyalash shartnomasiga ega. Orion Oyj 1917 yilda tashkil etilgan va shtab-kvartirasi Finlandiyaning Espoo shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Liisa Hurme Ph.D. | President, CEO & Chairman of Executive Management Board |
| Mr. Berkeley Vincent | Executive Vice President of Innovative Medicines & Member of Management Board |
| Mr. Hao Pan M.Sc. | Executive VP of the Branded Products & Member of the Exe. Mgmt. Board |
| Mr. Juhani Kankaanpaa M.Sc. | Executive VP of Global Operations & Member of Executive Management Board |
| Mr. Mikko Kemppainen | General Counsel, Secretary to the Board & Member of Executive Management Board |
| Mr. Niclas Lindstedt EMBA, M.Sc. |
There is no data to display
| Executive VP of Animal Health & Member of the Exe. Mgmt. Board |
| Mr. Rene Lindell M.Sc., Ph.D. | CFO & Member of Group Executive Management Board |
| Ms. Julia Irene Macharey | Executive VP of People & Culture & Member of Management Board |
| Ms. Satu Ahomäki M.Sc., M.Sc. (Econ.) | Executive VP of Generics and Consumer Health & Member of the Exe. Mgmt. Board |
| Prof. Outi Vaarala M.D., Ph.D. | Executive VP of Research & Development and Member of the Exe. Mgmt. Board |